Literature DB >> 10982332

Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.

D Y Wu1, A Krumm, W H Schubach.   

Abstract

The multiprotein human SWI-SNF (hSWI-SNF) complex is a chromatin-remodeling machine that facilitates transcription by overcoming chromatin-mediated gene repression. We had previously shown that hSNF5/INI1, an intrinsic, consistent component of the hSWI/SNF complex, is associated with Epstein-Barr nuclear antigen 2 (EBNA2) and have proposed that EBNA2 directs this complex to key EBNA2-responsive viral and cellular genes. Using chromatin immunoprecipitation and quantitative PCR, we show that antibodies directed against components of the hSWI-SNF complex preferentially precipitate chromatin-associated DNA that contains a targeted EBNA2-responsive element in the context of both episomal and cellular chromatin. This enrichment does not occur in EBNA2-negative cells or when the EBNA2-responsive element is mutated. The stable association of the hSWI-SNF complex with the EBNA2-responsive promoter can also be disrupted by deletion of the TATA element, suggesting that EBNA2 in itself is insufficient to mediate stable targeting of the hSWI-SNF complex. These results demonstrate that recruitment of the hSWI-SNF complex to selected promoters can occur in vivo through its interaction with site-specific activator proteins and that stable targeting may require the presence of basal transcription factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982332      PMCID: PMC102084          DOI: 10.1128/jvi.74.19.8893-8903.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity.

Authors:  D Chakravarti; V Ogryzko; H Y Kao; A Nash; H Chen; Y Nakatani; R M Evans
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

2.  Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

Authors:  S A Radkov; M Bain; P J Farrell; M West; M Rowe; M J Allday
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching.

Authors:  D O'Neill; J Yang; H Erdjument-Bromage; K Bornschlegel; P Tempst; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  The mammalian transcriptional repressor RBP (CBF1) targets TFIID and TFIIA to prevent activated transcription.

Authors:  I Olave; D Reinberg; L D Vales
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

5.  Long-distance transcriptional enhancement by the histone acetyltransferase PCAF.

Authors:  A Krumm; L Madisen; X J Yang; R Goodman; Y Nakatani; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

6.  The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain.

Authors:  L C Myers; C M Gustafsson; D A Bushnell; M Lui; H Erdjument-Bromage; P Tempst; R D Kornberg
Journal:  Genes Dev       Date:  1998-01-01       Impact factor: 11.361

7.  Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.

Authors:  M L Phelan; S Sif; G J Narlikar; R E Kingston
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

8.  BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription.

Authors:  P A Khavari; C L Peterson; J W Tamkun; D B Mendel; G R Crabtree
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

9.  Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors.

Authors:  S K Yoshinaga; C L Peterson; I Herskowitz; K R Yamamoto
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

10.  A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor.

Authors:  C Muchardt; M Yaniv
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  29 in total

1.  Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.

Authors:  Jae Myun Lee; Kyoung-Ho Lee; Magdalena Weidner; Barbara A Osborne; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

2.  EBNA3C coactivation with EBNA2 requires a SUMO homology domain.

Authors:  Adam Rosendorff; Diego Illanes; Gregory David; Jeffrey Lin; Elliott Kieff; Eric Johannsen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.

Authors:  Nathalie Alazard; Henri Gruffat; Edwige Hiriart; Alain Sergeant; Evelyne Manet
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

4.  CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation.

Authors:  Bogaslaw Kwiatkowski; Szu Yu Jenny Chen; William H Schubach
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Authors:  Alexey V Gordadze; Chisaroka W Onunwor; RongSheng Peng; David Poston; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.

Authors:  Rongsheng Peng; Stephanie C Moses; Jie Tan; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli.

Authors:  Jae Myun Lee; Kyoung-Ho Lee; Christopher J Farrell; Paul D Ling; Bettina Kempkes; Jeon Han Park; S Diane Hayward
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.

Authors:  Francesco Boccellato; Eleni Anastasiadou; Paola Rosato; Bettina Kempkes; Luigi Frati; Alberto Faggioni; Pankaj Trivedi
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

9.  Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

Authors:  Walter Lucchesi; Gareth Brady; Oliver Dittrich-Breiholz; Michael Kracht; Rainer Russ; Paul J Farrell
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

10.  Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

Authors:  Christopher J Farrell; Jae Myun Lee; Eui-Cheol Shin; Marek Cebrat; Philip A Cole; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.